Affiliation:
1. Rostov Research Institute of Oncology, Ministry of Health of Russia
2. Rostov Center of Urology, Nephrology, and Hemodialysis, Regional Hospital No. 2; Rostov Research Institute of Oncology, Ministry of Health of Russia
Abstract
Objective. Examination of the expression of genes responsible for hypoxia-dependent control of transcription, neoangiogenesis, and apoptosis in tumor tissue of the prostate, in patients with localized prostate cancer (РС) with biochemical recurrence (BR) and without recurrences after radical prostatectomy (RPE).Materials and methods. The main group included 56 patients with localized PC who had been diagnosed with BR within two years after RP. 60 patients with localized PC who did not relapse had a comparative group. 55 patients in whom operative biopsy specimens of the prostate gland were taken within healthy tissues with the removal of benign prostatic hyperplasia were combined into a control group. Determination of the expression level of the BAX, BCL2, VEGFA and HIF1α genes in tumor tissue was performed by real-time polymerase chain reaction.Results. In patients with localized PC after RPE, development of BR is associated with an increase in the expression of BCL2, VEGFA and HIF1α genes and a decrease in the expression of the BAX gene. In patients with localized PC and early recurrence of tumor tissue through a hypoxia-dependent factor that enhances transcritical processes in tumor cells, neoangiogenesis is activated, which is associated with inhibition of apoptosis of tumor cells by enhancing the expression of the antiapoptotic gene BCL2.Conclusion. Determination of the expression of BAX, BCL2, VEGFA and HIF1α genes in tumor tissue with localized PC allows further assessment of the risk of disease progression after surgical treatment.
Publisher
Publishing House ABV Press
Subject
Urology,Nephrology,Radiology Nuclear Medicine and imaging,Oncology,Surgery
Reference20 articles.
1. Sergeeva N.S., Skachkova T.E., Marshutina N.V. et al. Clinical significance of PSA-associated tests in the diagnosis and staging of prostate cancer. Onkologija = Oncology 2018;(1):55–67. (In Russ.)].
2. Guliev F.A. Predictors of biochemical progression of prostate cancer. Kazanskiy medicinskiy zhurnal = Kazan Medical Journal 2017;98(6):890–4. (In Russ.).
3. Coleman W.B. Molecular pathogenesis of prostate cancer. In: Molecular Pathology. 2nd Edn. The molecular basis of human disease. Eds.: W.B. Coleman, G. Tsongalis Elsevier Inc., 2018. Pp. 555–568. DOI: 10.1016/B978-0-12-802761-5.00025-0.
4. Bethel C.R., De Marzo A.M., Nelson W.G. Molecular pathogenesis of prostate cancer: somatic, epigenetic, and genetic alterations. In: Molecular pathology. The molecular basis of human disease. Eds. W.B. Coleman, G. Tsongalis. Elsevier Inc., 2009. Pp. 489–500. DOI: 10.1016/B978-0-12-374419-7.00024-X.
5. Kogan M.I., Chibichjan M.B., Vodolazhskij D.I. Change in the expression of genetic loci in the mononuclear fraction of peripheral blood of patients with prostate cancer. Klinicheskaya onkologiya = Clinical Oncology 2012;(5):59–60. (In Russ.).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献